Close Menu

NEW YORK (GenomeWeb) – Quanterix on Thursday announced the completion of an $8.5 million private placement led by T. Rowe Price.

The funding is a follow-on to the firm's Series D financing round, which raised $46 million in March 2016, and will be used to develop new instruments, expand Quanterix's assay menu, and "meet global demand for the company's proprietary platform across therapeutic markets," it said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.